BioSpace News Archive

With millions of Americans facing financial hardship, WebMD and Krames announced a new program designed to connect patients with pharmaceutical assistance programs, which can provide medications at low or no cost to those who cannot afford them.

Medela, the No. 1 mom-recommended breast pump brand*, announced the launch of the NEW Pump In Style with MaxFlow Technology double electric, personal-use breast pump in the U.S. and Canada.

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, and KYE Pharmaceuticals Inc. (“KYE”), a private company headquartered in Mississauga, Ontario and focused on bringing medicines that fulfill clinically significant unmet needs to the Canadian ma

– First milestone successfully achieved in early stages of the ongoing research project with McMaster University – Confirmed capability of PGX Technology to optimize and standardize the size and morphology of yeast beta-glucan (PGX-YBG) suitable for lung inhalation – In-vitro study with human cell lines demonstrated that PGX-YBG obtained from different sources exhibited significant stimulatory effect on human immune response

Study published in Critical Care journal shows patients with severe COVID-19 pneumonia treated with Auxora and standard of care had substantially improved outcomes compared to patients on standard of care alone Clinical trial to enroll up to 400 patients at sites across the U.S., including California, Texas and Louisiana, is being initiated this week

NGM Biopharmaceuticals, Inc. (NGM) (Nasdaq: NGM), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announced that comprehensive data from its 24-week Phase 2 study (Cohort 4) of aldafermin in patients with non-alcoholic steatohepatitis (NASH) will be featured in an oral plenary presentation at The Digital International Liver Congress (ILC) 2020, which will be held virtual

Blue Cross Blue Shield of Massachusetts (Blue Cross) has earned an “Excellent” accreditation rating from NCQA (1) for its clinical quality, member experience and performance against operational standards for Commercial HMO/POS and PPO plans, marking the fourth consecutive

Ernst & Young LLP (EY US) today announced that Daniel Pontecorvo of Camber Spine Technologies was named an Entrepreneur Of The Year® 2020 Greater Philadelphia Award finalist.

Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that Ted W. Love, M.D., has been appointed to the company’s Board of Directors. Dr. Love has more than 25 years of global experience in the healthcare and biotechnology/pharmaceutical industry and currently serves as President and Chief Executive Officer of Global Blood Therapeutics. “We are pleased to welcome Ted to our Board of Directors given his distinguished

MedShape, Inc., the industry leader in innovative NiTiNOL and other advanced material technologies, today announced that it has received a Technology/Therapeutic Development Award funded by the Department of Defense Peer Reviewed Medical Research Program (PRMRP)